Depression, medication adherence, and service utilization in systemic lupus erythematosus

Arthritis Care and Research

Volumn 61, Issue 2, 2009, Pages 240-246

  Julian, Laura J ^a,b   Yelin, Edward ^a   Yazdany, Jinoos ^a   Panopalis, Pantelis ^a   Trupin, Laura ^a   Criswell, Lindsey A ^a   Katz, Patricia ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Department of Medicine ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DEPRESSION; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; EMERGENCY HEALTH SERVICE; FEMALE; HEALTH CARE UTILIZATION; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; OUTPATIENT; PATIENT COMPLIANCE; PRIMARY MEDICAL CARE; RISK ASSESSMENT; SELF REPORT; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT OUTCOME;

ADULT; AMBULATORY CARE; COHORT STUDIES; DEPRESSION; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MEDICATION ADHERENCE; MIDDLE AGED; ODDS RATIO;

EID: 62549108150     PISSN: 21514658     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.24236     Document Type: Article

References (35)

1. Abu-Shakra M, Mader R, Langevitz P, Friger M, Codish S, Neumann L, et al. Quality of life in systemic lupus erythematosus: a controlled study. J Rheumatol 1999;26: 306-9.
2. Bernatsky S, Boivin JF, Joseph L, Manzi S, Ginzler E, Gladman DD, et al. Mortality in systemic lupus erythematosus. Arthritis Rheum 2006;54:2550-7.
3. Burra TA, Chen E, Mclntyre RS, Grace SL, Blackmore ER, Stewart DE. Predictors of self-reported antidepressant adherence. Behav Med 2007;32:127-34.
4. Barclay TR, Hinkin CH, Castellon SA, Mason KI, Reinhard MJ, Marion SD, et al. Age-associated predictors of medication adherence in HIV-positive adults: health beliefs, self-efficacy, and neurocognitive status. Health Psychol 2007;26:40-9.
5. Bulloch AG, Adair CE, Patten SB. Forgetfulness: a role in noncompliance with antidepressant treatment. Can J Psychiatry 2006;51:719-22.
6. Miller NH. Compliance with treatment regimens in chronic asymptomatic diseases. Am J Med 1997;102:43-9.
7. Rand CS. Measuring adherence with therapy for chronic diseases: implications for the treatment of heterozygous familial hypercholesterolemia. Am J Cardiol 1993;72:68D-74D.
8. Gehi A, Haas D, Pipkin S, Whooley MA. Depression and medication adherence in outpatients with coronary heart disease: findings from the heart and soul study. Arch Intern Med 2005;165:2508-13.
9. Gonzalez JS, Safren SA, Cagliero E, Wexler DJ, Delahanty L, Wittenberg E, et al. Depression, self-care, and medication adherence in type 2 diabetes: relationships across the full range of symptom severity. Diabetes Care 2007;30:2222-7.
10. Mosley-Williams A, Lumley MA, Gillis M, Leisen J, Guice D. Barriers to treatment adherence among African American and white women with systemic lupus erythematosus. Arthritis Rheum 2002;47:630-8.
11. Petri M, Perez-Gutthann S, Longenecker JC, Hochberg M. Morbidity of systemic lupus erythematosus: role of race and socioeconomic status. Am J Med 1991;91:345-53.
12. Adler M, Chambers S, Edwards C, Neild G, Isenberg D. An assessment of renal failure in an SLE cohort with special reference to ethnicity, over a 25-year period. Rheumatology (Oxford) 2006;45:1144-7.
13. Rojas-Serrano J, Cardiel MH. Lupus patients in an emergency unit: causes of consultation, hospitalization and outcome. A cohort study. Lupus 2000;9:601-6.
14. Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care 2005;43:521-30.
15. Balkrishnan R, Rajagopalan R, Camacho FT, Huston SA, Murray FT, Anderson RT. Predictors of medication adherence and associated health care costs in an older population with type 2 diabetes mellitus: a longitudinal cohort study. Clin Ther 2003;25:2958-71.
16. Lew KH, Chang EY, Rajagopalan K, Knoth RL. The effect of medication adherence on health care utilization in bipolar disorder. Manag Care Interface 2006;19:41-6.
17. Ho PM, Rumsfeld JS, Masoudi FA, McClure DL, Plomondon ME, Steiner JF, et al. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med 2006;166:1836-41.
18. Hochberg MC, for the Diagnostic and Therapeutic Criteria Committee of the American College of Rheumatology. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 1997;40:1725.
19. Yelin E, Trupin L, Katz P, Criswell L, Yazdany J, Gillis J, et al. Work dynamics among persons with systemic lupus erythematosus. Arthritis Rheum 2007;57:56-63.
20. Malouff JM, Schutte NS, Ramerth W. Evaluation of a short form of the POMS-depression scale. J Clin Psychol 1985;41:389-91.
21. Pincus T. A self-report cognitive symptoms inventory to assess patients with rheumatic diseases: results in eosinophilia-myalgia syndrome (EMS), fibromyalgia, rheumatoid arthritis (RA), and other rheumatic diseases [abstract]. Arthritis Rheum 1996;39 Suppl 9:S261.
22. Karlson EW, Daltroy LH, Rivest C, Ramsey-Goldman R, Wright EA, Partridge AJ, et al. Validation of a Systemic Lupus Activity Questionnaire (SLAQ) for population studies. Lupus 2003;12:280-6.
23. Yazdany J, Yelin E, Panopalis P, Trupin L, Julian L, Katz P. Validation of the Systemic Lupus Erythematosus Activity Questionnaire in a large observational cohort. Arthritis Rheum 2008;59:136-43.
24. Radloff LS. The CES-D scale: a self-report depression measure for research in the general population. Appl Psychol Meas 1977;1:385-401.
25. Brandt J, Benedict RH. Hopkins verbal learning test: revised. Lutz (FL): Psychological Assessment Resources; 2001.
26. Maruyama GM. Basics of structural equation modeling. Thousand Oaks (CA): Sage; 1997.
27. Pullar T, Peaker S, Martin MF, Bird HA, Feely MP. The use of a pharmacological indicator to investigate compliance in patients with a poor response to antirheumatic therapy. Rheumatology (Oxford) 1988;27:381-4.
28. Heller RF, Rose G, Pedoe HD, Christie DG. Blood pressure measurement in the United Kingdom Heart Disease Prevention Project. J Epidemiol Community Health 1978;32:235-8.
29. Reid D, Abramson M, Raven J, Walters HE. Management and treatment perceptions among young adults with asthma in Melbourne: the Australian experience from the European Community Respiratory Health Survey. Respirology 2000;5:281-7.
30. Rieckmann N, Kronish IM, Haas D, Gerin W, Chaplin WF, Burg MM, et al. Persistent depressive symptoms lower aspirin adherence after acute coronary syndromes. Am Heart J 2006; 152:922-7.
31. Mohr DC, Goodkin DE, Likosky W, Gatto N, Baumann KA, Rudick RA. Treatment of depression improves adherence to interferon β-1b therapy for multiple sclerosis. Arch Neurol 1997;54:531-3.
32. Spector SL, Kinsman R, Mawhinney H, Siegel SC, Rachel-efsky GS, Katz RM, et al. Compliance of patients with asthma with an experimental aerosolized medication: implications for controlled clinical trials. J Allergy Clin Immunol 1986;77:65-70.
33. Zeller A, Schroeder K, Peters TJ. An adherence self-report questionnaire facilitated the differentiation between nonadherence and nonresponse to antihypertensive treatment. J Clin Epidemiol 2008;61:282-8.
34. Schroeder K, Fahey T, Hay AD, Montgomery A, Peters TJ. Adherence to antihypertensive medication assessed by self-report was associated with electronic monitoring compliance. J Clin Epidemiol 2006;59:650-1.
35. Norell SE. Accuracy of patient interviews and estimates by clinical staff in determining medication compliance. Soc Sci Med E 1981;15:57-61.